Methods and systems for stimulation as a therapy for erectile dysfunction

• US 20050240229A1
• Filed: 05/31/2005
• Published: 10/27/2005
• Est. Priority Date: 04/26/2001
• Status: Abandoned Application

• Current Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Inventors: Whitehurst, Tood K., Jaax, Kristen N., McGivern, James P., Makous, James C.
• Application Number:
  US11/141,443
• Publication Number:
  US 20050240229A1
• Time in Patent Office: Days
• US Class Current: 607/2
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/372 Arrangements in connection with the implantation of stimulators
• CPC Class Codes: A61N 1/37205 Microstimulators, e.g. implantable through a cannula
• CPC Class Codes: A61N 1/37211 Means for communicating with stimulators

Abstract

Systems and methods for stimulating tissue affecting the penis to treat erectile dysfunction may include stimulation using at least one implantable system control unit (SCU).

Claims

1. A method comprising:

providing a system control unit;

delivering stimulation pulses from the system control unit to tissue affecting the penis of a patient;

wherein the patient suffers from erectile dysfunction; and

wherein delivering stimulation pulses from the system control unit to tissue affecting the penis of a patient includes delivering stimulation pulses via current steering.

2. The method of claim 1 further comprising:

providing a lead, wherein the lead includes at least one stimulating electrode at a distal portion of the lead;

connecting the system control unit to a proximal portion of the lead for the patient;

providing operating power to the system control unit;

providing stimulation parameters to the system control unit; and

generating the stimulation pulses in accordance with the stimulation parameters.

3. The method of claim 2 wherein the stimulation pulses are electrical pulses.

4. The method of claim 2 wherein the tissue affecting the penis comprises one or more of the sympathetic ganglia from which the hypogastric nerves arise, the hypogastric nerves, the nerves of the inferior hypogastric plexus, and the nerves of the branches of the inferior hypogastric plexus.

5. The method of claim 2 wherein the tissue affecting the penis comprises at least one of the corpus cavernosa, corpus spongiosum, cavernous nerves, nerves of the prostatic plexus, branches of the prostatic plexus, pelvic splanchnic nerves, second, third, and fourth sacral nerves, sympathetic ganglia from which the hypogastric nerves arise, hypogastric nerves, nerves of the inferior hypogastric plexus, branches of the inferior hypogastric plexus, branches of the inferior hypogastric plexus that innervate at least one of the prostate, seminal vesicles, and vas deferens, pelvic splanchnic nerves leading to the prostate, blood vessels supplying the penis, blood vessels draining the penis, internal iliac arteries, internal pudendal arteries, dorsal arteries of the penis, deep arteries of the penis, the deep dorsal vein of the penis, and the urethra.

6. The method of claim 1 wherein the tissue affecting the penis supplies parasympathetic input that promotes erection and wherein the tissue affecting the penis comprises at least one nerve of the cavernous nerves, the prostatic plexus, branches of the prostatic plexus, the pelvic splanchnic nerves, and the second, third, and fourth sacral nerves.

7. The method of claim 2 wherein the tissue affecting the penis affects emission or ejaculation.

8. The method of claim 7 wherein the tissue affecting the penis comprises at least one nerve of the branches of the inferior hypogastric plexus that innervate at least one of the prostate, seminal vesicles, and vas deferens.

9. The method of claim 7 wherein the at least one nerve comprises at least one of the pelvic splanchnic nerves leading to the prostate.

10. The method of claim 1 wherein delivering stimulation pulses from the system control unit to tissue affecting the penis of a patient includes delivering stimulation pulses to tissue responsible for promoting an erection and delivering stimulation pulses to tissue responsible for promoting ejaculation.

11. The method of claim 10 further comprising determining a preferred set of stimulation parameters of the system control unit to maximize erection and ejaculation with little to no pain.

12. A method comprising:

providing a system control unit;

providing a catheter connected to the system control unit at a proximal portion of the catheter, wherein the catheter includes at least one infusion outlet at a distal portion of the catheter;

delivering stimulation pulses from the system control unit to tissue affecting the penis of a patient;

wherein the patient suffers from erectile dysfunction; and

wherein delivering stimulation pulses from the system control unit to tissue affecting the penis of a patient includes delivering stimulation pulses via selective drug infusion.

13. The method of claim 12 wherein the tissue affecting the penis comprises one or more of the sympathetic ganglia from which the hypogastric nerves arise, the hypogastric nerves, the nerves of the inferior hypogastric plexus, and the nerves of the branches of the inferior hypogastric plexus.

14. The method of claim 12 wherein the tissue affecting the penis comprises at least one of the corpus cavernosa, corpus spongiosum, cavernous nerves, nerves of the prostatic plexus, branches of the prostatic plexus, pelvic splanchnic nerves, second, third, and fourth sacral nerves, sympathetic ganglia from which the hypogastric nerves arise, hypogastric nerves, nerves of the inferior hypogastric plexus, branches of the inferior hypogastric plexus, branches of the inferior hypogastric plexus that innervate at least one of the prostate, seminal vesicles, and vas deferens, pelvic splanchnic nerves leading to the prostate, blood vessels supplying the penis, blood vessels draining the penis, internal iliac arteries, internal pudendal arteries, dorsal arteries of the penis, deep arteries of the penis, the deep dorsal vein of the penis, and the urethra.

15. The method of claim 12 wherein the tissue affecting the penis supplies parasympathetic input that promotes erection and wherein the tissue affecting the penis comprises at least one nerve of the cavernous nerves, the prostatic plexus, branches of the prostatic plexus, the pelvic splanchnic nerves, and the second, third, and fourth sacral nerves.

16. The method of claim 12 wherein delivering stimulation pulses from the system control unit to tissue affecting the penis of a patient includes delivering stimulation pulses to tissue responsible for promoting an erection and delivering stimulation pulses to tissue responsible for promoting ejaculation.

17. The method of claim 16 further comprising determining a preferred set of stimulation parameters of the system control unit to maximize erection and ejaculation with little to no pain.

18. The method of claim 12 wherein the stimulation pulses are infusion pulses providing at least one of an opiate, a CGRP antagonist, and a substance P antagonist.

19. A system comprising:

a system control unit configured to apply stimulation through a multiplicity of output channels; and

at least one lead electrically connected to the system control unit, the at least one lead including at least one stimulating electrode; and

wherein at least two stimulating electrodes deliver stimulation pulses via current steering to tissue affecting the penis of a patient.

20. The system of claim 19, further comprising at least one cuff electrode connected to the lead.